# Sleep Number Corp: Form 10-Q for the period ended Jun 28, 2025

- Company: [Sleep Number Corp](/companies/snbrq.md) (CIK 827187)
- Form: 10-Q
- Filed: 2025-07-31
- Accepted by EDGAR: Jul 31, 2025, 16:01 ET
- Period: 2025-06-28
- Accession: 0000827187-25-000103
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/827187/000082718725000103/snbr-20250628.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/827187/000082718725000103/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-06-28.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2025-03-30 to 2025-06-28 | $327.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months, 2024-12-29 to 2025-06-28 | $721.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2025-03-30 to 2025-06-28 | $134.2m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months, 2024-12-29 to 2025-06-28 | $286.9m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2025-03-30 to 2025-06-28 | $193.7m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2024-12-29 to 2025-06-28 | $434.3m | us-gaap:GrossProfit |
| Research and development | 3 months, 2025-03-30 to 2025-06-28 | $9.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2024-12-29 to 2025-06-28 | $20.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2025-03-30 to 2025-06-28 | −$75.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2024-12-29 to 2025-06-28 | $1.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2025-03-30 to 2025-06-28 | $11.7m | us-gaap:InterestExpenseNonoperating |
| Interest expense | 6 months, 2024-12-29 to 2025-06-28 | $22.8m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months, 2025-03-30 to 2025-06-28 | $13.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2024-12-29 to 2025-06-28 | $12.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2025-03-30 to 2025-06-28 | −$25.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2024-12-29 to 2025-06-28 | −$33.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2025-03-30 to 2025-06-28 | −$1.09 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2024-12-29 to 2025-06-28 | −$1.48 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2025-03-30 to 2025-06-28 | −$1.09 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2024-12-29 to 2025-06-28 | −$1.48 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2025-03-30 to 2025-06-28 | 22,903,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2024-12-29 to 2025-06-28 | 22,804,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2024-12-29 to 2025-06-28 | $1.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2024-12-29 to 2025-06-28 | $8.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months, 2024-12-29 to 2025-06-28 | $944.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2025-06-28 | $1.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2025-06-28 | $175.5m | us-gaap:AssetsCurrent |
| Total assets | at 2025-06-28 | $804.5m | us-gaap:Assets |
| Current liabilities | at 2025-06-28 | $903.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2025-06-28 | $1.29bn | us-gaap:Liabilities |
| Current portion of debt | at 2025-06-28 | $563.9m | us-gaap:DebtCurrent |
| Shareholders' equity | at 2025-06-28 | −$480.7m | us-gaap:StockholdersEquity |
| Shares outstanding | at 2025-06-28 | 22,771,000 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/827187/000082718725000103/snbr-20250628.htm

Filed Jul 31, 2025.
Source: SEC EDGAR, the filing index for accession 0000827187-25-000103. Last ingested by Listed: Oct 24, 2026, 14:57 ET. No prices; not investment advice.
